Tau-MEDICAL Co., Ltd.
11
4
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1
Role: collaborator
Acute Safety and Efficacy of the Pivot Bridge System for Functional Tricuspid Regurgitation
Role: lead
Early Phase Study Using the 'Pivot Extend' System as a Treatment for Patients With Tricuspid Regurgitation
Role: collaborator
First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation
Role: lead
Evaluation of Safety and Efficacy of Pivot Balloon to Monitoring Acute RV Failure and Reduction of FTR
Role: lead
The Study for Evaluate of Safety and Efficacy of Vein of Marshall RF Ablation
Role: lead
Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment
Role: lead
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat FTR
Role: lead
Atrial Functional Mitral Regurgitation Response In Mitral Loop Cerclage Annuloplasty (AFRICA Study)
Role: lead
The Effect of "Cerclage Pacing" for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT)
Role: lead
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
Role: lead
All 11 trials loaded